• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例通过左前小切口开胸对植入左心室辅助装置且出现电风暴的患者进行高密度心外膜标测与消融:病例报告

First-in-human high-density epicardial mapping and ablation through a left anterior minithoracotomy in an LVAD patient presenting in electrical storm: a case report.

作者信息

El Hamriti Mustapha, Fox Henrik, Sommer Philipp, Rojas Sebastian V

机构信息

Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Georgstr. 11, 32545 Bad Oeynhausen, Germany.

Clinic for Cardio and Thoracic Surgery, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Georgstr. 11, 32545 Bad Oeynhausen, Germany.

出版信息

Eur Heart J Case Rep. 2021 Jun 26;5(6):ytab248. doi: 10.1093/ehjcr/ytab248. eCollection 2021 Jun.

DOI:10.1093/ehjcr/ytab248
PMID:34189403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8233488/
Abstract

BACKGROUND

Despite substantial technical improvements in long-term mechanical circulatory support, ventricular tachycardia (VT) remains a major challenge in left ventricular assist device (LVAD) patients. Recurrent VTs in LVAD patients are not only associated with limited quality of life, but also increased mortality. Although LVAD therapy improves VT tolerance of the left ventricle, haemodynamical deterioration of the right ventricle is the limiting factor in these patients.

CASE SUMMARY

We present a case report of a hybrid epicardial VT ablation of incessant VTs in a 53-year-old man with advanced heart failure and St.p. LVAD implantation. With this unique clinical case report, we describe an epicardial VT ablation using secondary surgical open-heart access in a patient with therapy-refractory VTs combing left-sided minithoracotomy with high-density (HD) mapping and catheter ablation.

DISCUSSION

To the best of our knowledge, the presented approach is the first interdisciplinary case of epicardial VT ablation using secondary surgical open-heart access in an LVAD patient with therapy-refractory VTs. By combing left-sided minithoracotomy with HD mapping and catheter ablation, we could to demonstrate that even in these complex patients epicardial VT ablations can be performed safely and improve quality of life of LVAD patients with recurrent implantable cardioverter-defibrillator shock therapies.

摘要

背景

尽管长期机械循环支持技术有了显著改进,但室性心动过速(VT)仍是左心室辅助装置(LVAD)患者面临的主要挑战。LVAD患者反复发生VT不仅与生活质量受限有关,还会增加死亡率。尽管LVAD治疗提高了左心室对VT的耐受性,但右心室的血流动力学恶化是这些患者的限制因素。

病例总结

我们报告一例53岁晚期心力衰竭且植入St.p LVAD的男性患者,对持续性VT进行混合心外膜VT消融的病例。通过这个独特的临床病例报告,我们描述了在一名VT治疗难治性患者中,采用二次外科开胸入路,结合左侧小切口胸廓切开术、高密度(HD)标测和导管消融进行心外膜VT消融。

讨论

据我们所知,所介绍的方法是首例在LVAD植入且VT治疗难治性患者中采用二次外科开胸入路进行心外膜VT消融的跨学科病例。通过将左侧小切口胸廓切开术与HD标测和导管消融相结合,我们能够证明,即使在这些复杂患者中,心外膜VT消融也可安全进行,并改善反复接受植入式心律转复除颤器电击治疗的LVAD患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/2050f02b3ee7/ytab248f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/1a3a07a3520f/ytab248f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/8af2b0b03a28/ytab248f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/31973b1c9e2f/ytab248f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/71acecaae0b1/ytab248f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/c5e5aca050f7/ytab248f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/2050f02b3ee7/ytab248f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/1a3a07a3520f/ytab248f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/8af2b0b03a28/ytab248f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/31973b1c9e2f/ytab248f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/71acecaae0b1/ytab248f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/c5e5aca050f7/ytab248f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c014/8233488/2050f02b3ee7/ytab248f8.jpg

相似文献

1
First-in-human high-density epicardial mapping and ablation through a left anterior minithoracotomy in an LVAD patient presenting in electrical storm: a case report.首例通过左前小切口开胸对植入左心室辅助装置且出现电风暴的患者进行高密度心外膜标测与消融:病例报告
Eur Heart J Case Rep. 2021 Jun 26;5(6):ytab248. doi: 10.1093/ehjcr/ytab248. eCollection 2021 Jun.
2
Open-chest epicardial ablation of ventricular tachycardia during a left ventricular assist device implantation: a case report.在植入左心室辅助装置期间进行开胸心外膜室性心动过速消融术:一例报告
Eur Heart J Case Rep. 2023 Jun 23;7(7):ytad277. doi: 10.1093/ehjcr/ytad277. eCollection 2023 Jul.
3
Video assisted thoracoscopic sympathectomy for intractable recurrent VT after minimal-invasive LVAD implantation.微创左心室辅助装置植入术后难治性复发性室性心动过速的电视辅助胸腔镜交感神经切除术
J Card Surg. 2020 Jul;35(7):1708-1710. doi: 10.1111/jocs.14639. Epub 2020 May 21.
4
Safety and Feasibility of Open Chest Epicardial Mapping and Ablation of Ventricular Tachycardia During the Period of Left Ventricular Assist Device Implantation.左心室辅助装置植入期间开胸心外膜标测及室性心动过速消融的安全性与可行性
J Cardiovasc Electrophysiol. 2016 Jan;27(1):95-101. doi: 10.1111/jce.12839. Epub 2015 Nov 4.
5
Catheter ablation of electrical storm in a patient with left ventricular assist device.左心室辅助装置患者电风暴的导管消融术
Herzschrittmacherther Elektrophysiol. 2014 Jun;25(2):102-4. doi: 10.1007/s00399-014-0311-0.
6
Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.基于基质的消融对频发恰当的植入型心律转复除颤器治疗和扩张型心肌病患者室性心动过速的影响:高密度标测的长期经验。
Rev Port Cardiol (Engl Ed). 2021 Nov;40(11):865-873. doi: 10.1016/j.repce.2021.11.006.
7
Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.左心室辅助装置植入者难治性室性心动过速的成功开胸心外膜消融术
JACC Case Rep. 2021 Apr 14;3(7):1055-1060. doi: 10.1016/j.jaccas.2021.02.007. eCollection 2021 Jul 7.
8
Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience.左心室辅助装置植入术后作为终点治疗的室性心动过速的特征:单中心消融经验。
JACC Clin Electrophysiol. 2017 Dec 11;3(12):1412-1424. doi: 10.1016/j.jacep.2017.05.012. Epub 2017 Aug 2.
9
[Initial experience of catheter ablation of ventricular tachycardia originate from endocardium via direct ventricle puncture access in patients underwent mechanical valve implantation].[经直接心室穿刺途径对机械瓣膜置换术后患者起源于心内膜的室性心动过速进行导管消融的初步经验]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Mar 24;46(3):213-217. doi: 10.3760/cma.j.issn.0253-3758.2018.03.009.
10
Extracorporeal Membrane Oxygenation for Hemodynamic Support of Ventricular Tachycardia Ablation.用于室性心动过速消融血流动力学支持的体外膜肺氧合
Circ Arrhythm Electrophysiol. 2016 Dec;9(12). doi: 10.1161/CIRCEP.116.004492.

引用本文的文献

1
[Epicardial ablation of ventricular tachycardia with cardiac surgery only : Pro/Contra].[仅通过心脏手术进行室性心动过速的心外膜消融:支持/反对]
Herzschrittmacherther Elektrophysiol. 2024 Dec;35(4):286-289. doi: 10.1007/s00399-024-01038-6. Epub 2024 Sep 2.
2
The Role of Daily Implant-Based Multiparametric Telemonitoring in Patients with a Ventricular Assist Device.基于植入物的每日多参数远程监测在心室辅助装置患者中的作用
Life (Basel). 2022 Dec 23;13(1):38. doi: 10.3390/life13010038.
3
Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience.

本文引用的文献

1
Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®.比较HeartWare® HVAD®和雅培® HeartMate 3®植入后的短期结果。
ESC Heart Fail. 2020 Jun;7(3):908-914. doi: 10.1002/ehf2.12649. Epub 2020 Mar 19.
2
Permanent Implantable Cardiac Support Systems.永久性植入式心脏支持系统。
Dtsch Arztebl Int. 2019 Dec 13;116(50):843-848. doi: 10.3238/arztebl.2019.0843.
3
Comparison of the Ventricular Tachycardia Circuit Between Patients With Ischemic and Nonischemic Cardiomyopathies: Detailed Characterization by Entrainment.
HeartWare 心室辅助装置血栓形成患者溶栓治疗的演变:单中心经验。
Interact Cardiovasc Thorac Surg. 2022 Jun 15;35(1). doi: 10.1093/icvts/ivac054.
4
Lessons learned from catheter ablation of ventricular arrhythmias in patients with a fully magnetically levitated left ventricular assist device.从完全磁悬浮左心室辅助装置患者的室性心律失常导管消融中吸取的教训。
Clin Res Cardiol. 2022 May;111(5):574-582. doi: 10.1007/s00392-021-01958-0. Epub 2021 Oct 28.
缺血性与非缺血性心肌病患者室性心动过速环路的比较:通过拖带进行详细特征描述。
Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007249. doi: 10.1161/CIRCEP.119.007249. Epub 2019 Jul 12.
4
Catheter Ablation of Ventricular Tachycardia in Patients With a Ventricular Assist Device: A Systematic Review of Procedural Characteristics and Outcomes.经皮导管消融治疗心室辅助装置患者室性心动过速:手术特点和结局的系统评价。
JACC Clin Electrophysiol. 2019 Jan;5(1):39-51. doi: 10.1016/j.jacep.2018.08.009. Epub 2018 Sep 26.
5
Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia.瘢痕匀化与局限性基质消融治疗非缺血性心肌病伴室性心动过速患者的比较。
J Am Coll Cardiol. 2016 Nov 1;68(18):1990-1998. doi: 10.1016/j.jacc.2016.08.033.
6
Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study).在植入了植入式心律转复除颤器(ICD)的连续血流左心室辅助装置(LVAD)受者中,与室性快速心律失常相关的低心输出量(低心输出量室性心动过速研究)
J Heart Lung Transplant. 2014 Mar;33(3):318-20. doi: 10.1016/j.healun.2013.11.005. Epub 2013 Nov 28.
7
Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.植入式心脏复律除颤器在左心室辅助装置支持心力衰竭患者中的生存获益。
J Card Fail. 2012 Feb;18(2):140-5. doi: 10.1016/j.cardfail.2011.10.020. Epub 2011 Dec 22.
8
Successful ablation of an epicardial ventricular tachycardia using a surgical ablation tool.
Circ Arrhythm Electrophysiol. 2011 Dec;4(6):e84-6. doi: 10.1161/CIRCEP.111.965467.
9
Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator.植入式心律转复除颤器可改善心室辅助装置受者的存活率。
Heart Rhythm. 2010 Apr;7(4):466-71. doi: 10.1016/j.hrthm.2009.12.022. Epub 2010 Jan 4.
10
Long-term use of a left ventricular assist device for end-stage heart failure.终末期心力衰竭患者长期使用左心室辅助装置。
N Engl J Med. 2001 Nov 15;345(20):1435-43. doi: 10.1056/NEJMoa012175.